Adial Pharmaceuticals, Inc

ADILNASDAQ • USD
1.63 USD
↗ 0.06 (3.82%)🟢LIVE (AS OF 01:11 PM EDT)
🟢Market: OPEN
Open?$1.59
High?$1.64
Low?$1.48
Prev. Close?$1.57
Volume?27.5K
Avg. Volume?141.5K
VWAP?$1.61
Rel. Volume?0.19x
Bid / Ask
Bid?$1.62 × 100
Ask?$4.00 × 200
Spread?$2.38
Midpoint?$2.81
Valuation & Ratios
Market Cap?2.2M
Shares Out?1.4M
Float?1.4M
Float %?98.6%
P/E Ratio?N/A
P/B Ratio?0.42
EPS?-$5.59
Dividend?0.00%
Ex-Dividend?N/A
Technical Outlook
Loading...
Fundamental Outlook
Loading...
Short Interest
Loading...
Financial Health
Current Ratio?4.42Strong
Quick Ratio?4.42Strong
Cash Ratio?4.21Strong
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUED
Score
100/100
P/E?
N/A▾
P/B?
0.42CHEAP▾
P/S?
N/A▾
P/FCF?
N/A▾
EV/EBITDA?
0.5CHEAP▾
EV/Sales?
N/A▾
Returns & Efficiency
ROE?
-151.2%WEAK▾
ROA?
-119.5%WEAK▾
Cash Flow & Enterprise
FCF?N/A
Enterprise Value?$-3639304
Related Companies
Loading...
News
Profile
Adial Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on the development of therapeutics for the treatment or prevention of addiction and related disorders. Its investigational new drug candidate, AD04, is being developed as a therapeutic agent for the treatment of alcohol use disorder. The company operates as one operating segment with a focus on drug development for addiction and related disorders.
Employees
6
Market Cap
2.2M
Industry
PHARMACEUTICAL PREPARATIONS
Website
www.adial.com
Listed
2018-07-27
Address
1180 SEMINOLE TRAIL
CHARLOTTESVILLE, VA 22901
Phone: 434-422-9800
MarketsMoversWatchlist